tirzepatide and fainting vs. Semaglutide for Weight Loss Tirzepatide Medication Guide - Nervana

Tirzepatide is a novel injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management in adults

Severe side effects of the medication are: Severe gastrointestinal problems Low blood sugar levels (hypoglycemia) Changes in vision due to diabetic retinopathy pancreatitis Gallbladder problems Hypoglycemia Allergic reaction to the medication Severe stomach pain Risk of aspiration during sedation or anesthesia Mood and behavioural changes Suicidal ideation Limitations Semaglutide is contraindicated for patients with a history or family history of thyroid cell tumors (MTC) and endocrine cancers (MEN 2 syndrome) because the medication increases the risk of these tumors in rodent studies

Rare postmarketing cases of pulmonary aspiration from retained stomach contents have been reported in GLP-1-treated patients, even after following the recommended preoperative fast

A key development was its approval and launch in India in September 2023, marking a significant entry into a high-potential market with a rising diabetes and obesity burden

We were curious to learn if there has been an increase in the frequency of new GLP-1 prescriptions and how often they were prescribed on-label (for people with the FDA-approved indication) vs

Each step is tailored to your health profile, goals, and metabolic needs